000 | 01821 a2200445 4500 | ||
---|---|---|---|
005 | 20250516023514.0 | ||
264 | 0 | _c20110620 | |
008 | 201106s 0 0 eng d | ||
022 | _a1873-264X | ||
024 | 7 |
_a10.1016/j.jpba.2011.01.019 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOswald, Stefan | |
245 | 0 | 0 |
_aLC-MS/MS method for the simultaneous determination of clarithromycin, rifampicin and their main metabolites in horse plasma, epithelial lining fluid and broncho-alveolar cells. _h[electronic resource] |
260 |
_bJournal of pharmaceutical and biomedical analysis _cApr 2011 |
||
300 |
_a194-201 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Validation Study | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xblood |
650 | 0 | 4 | _aBiotransformation |
650 | 0 | 4 |
_aBronchioles _xcytology |
650 | 0 | 4 |
_aBronchoalveolar Lavage Fluid _xchemistry |
650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xveterinary |
650 | 0 | 4 |
_aClarithromycin _xanalogs & derivatives |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aDrug Stability |
650 | 0 | 4 |
_aHorse Diseases _xblood |
650 | 0 | 4 | _aHorses |
650 | 0 | 4 | _aLimit of Detection |
650 | 0 | 4 |
_aPulmonary Alveoli _xcytology |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 |
_aRespiratory Tract Infections _xblood |
650 | 0 | 4 |
_aRifampin _xanalogs & derivatives |
650 | 0 | 4 |
_aSpectrometry, Mass, Electrospray Ionization _xveterinary |
650 | 0 | 4 |
_aTandem Mass Spectrometry _xveterinary |
700 | 1 | _aPeters, Jette | |
700 | 1 | _aVenner, Monica | |
700 | 1 | _aSiegmund, Werner | |
773 | 0 |
_tJournal of pharmaceutical and biomedical analysis _gvol. 55 _gno. 1 _gp. 194-201 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpba.2011.01.019 _zAvailable from publisher's website |
999 |
_c20588241 _d20588241 |